19 completed, 4 unknown. 23 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 23 | Completed 19, Unknown 4 |
Follow Chronic Renal Failure: new trials by email Literature Review of Chronic Renal Failure trials Research Report on Chronic Renal Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treating Hepatitis C in CRF Using Sofosbuvir and Daclatasvir Sofosbuvir 400 mg and daclatasvir 60 mg - Hepatitis C, Chronic, Chronic Renal Failure | Phase 4 | Completed | Tehran University of Medical Sciences | 95 | 2017-04-01 | 2019-09-30 |
| Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. Somatropin - Short Stature, Idiopathic, Infant, Small for Gestational Age | Phase 4 | Completed | LG Life Sciences | 116 | 2016-08-11 | 2019-01-03 |
| Phase Ⅳ Clinical Trial to Evaluate of Renamezin in Patients With Chronic Renal Failure. Renamezin capsule - Chronic Renal Failure | Phase 4 | Completed | Daewon Pharmaceutical Co., Ltd. | 110 | 2016-01-01 | 2017-07-06 |
| A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-dialysis Patients With Chronic Renal Failure Renamezin capsule, Kremezin granule - Chronic Renal Failure | Phase 4 | Completed | Daewon Pharmaceutical Co., Ltd. | 153 | 2015-12-01 | 2017-07-06 |
| the Effect of Calcium Dobesilate on Non Dialysis Patients With CKD Calcium Dobesilate group, Conventional Treatment group - Chronic Renal Failure | Phase 4 | Unknown | The Affiliated Hospital of Xuzhou Medical University | 100 | 2015-01-01 | 2018-02-14 |
| Dose-finding of Rivaroxaban in Hemodialysis Rivaroxaban 10 mg - Chronic Renal Failure | Phase 4 | Completed | AZ Sint-Jan AV | 18 | 2013-09-01 | 2015-01-14 |
| Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes Linagliptin, Placebo - Type 2 Diabetes, Chronic Renal Failure | Phase 4 | Completed | University of Padova | 45 | 2012-09-01 | 2014-12-19 |
| The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal Dialysis Solution B (balance PD solution), Solution A (conventional PD solution) - Chronic Renal Failure | Phase 4 | Completed | Fresenius Medical Care Deutschland GmbH | 25 | 2011-07-01 | 2016-05-02 |
| Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD) ARB, Pentoxifylline, Placebo (for Pentoxifylline) - Chronic Renal Failure | Phase 4 | Unknown | National Taiwan University Hospital | 350 | 2010-06-01 | 2016-10-14 |
| Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndEergoing Coronary Angiography (PRINCIPLE Study) pretreatment with intravenous nicorandil vs. placebo before coronary angiography - Chronic Renal Failure | Phase 4 | Completed | Yonsei University | 173 | 2010-03-01 | 2012-02-06 |
| Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients Everolimus, Tacrolimus (FK506), Basiliximab - Chronic Renal Failure | Phase 4 | Completed | Novartis Pharmaceuticals | 36 | 2009-12-01 | 2014-08-15 |
| Study of Erythropoietin (EPO) Administration Schedule recomon (Epoetin Beta) - Chronic Renal Failure, Anaemia | Phase 4 | Completed | JW Pharmaceutical | 60 | 2009-10-01 | 2014-05-14 |
| Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure N-acetylcysteine - Chronic Renal Failure | Phase 4 | Unknown | Osaka General Medical Center | 2008-07-01 | 2008-07-15 | |
| NAC in Preventing CIN in CRF Patients Who Need Enhanced CT Scan in ED NAC Bicarbonate - Chronic Renal Failure | Phase 4 | Unknown | Seoul National University Hospital | 2007-03-01 | 2010-07-27 | |
| ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis cinacalcet - Chronic Kidney Disease, End Stage Renal Disease | Phase 4 | Completed | Amgen | 360 | 2006-09-01 | 2014-07-23 |
| Efficacy of Intravenous Iron Administration in Hemodialysis Patients chondroitin sulfate-iron colloid - Chronic Renal Failure, Hemodialysis | Phase 4 | Completed | Kumamoto University | 50 | 2005-06-01 | 2008-05-12 |
| Effects of Cyclosporine A on Pancreatic Insulin Secretion cyclosporine A - Chronic Renal Failure | Phase 4 | Completed | University of Oslo School of Pharmacy | 16 | 2005-04-01 | 2012-11-02 |
| Administration of pH-Neutral Peritoneal Dialysis Solutions Containing Lactate or Bicarbonate in Children lactate and bicarbonate buffered dialysis solutions - Chronic Renal Failure, Peritoneal Membrane Disorder | Phase 4 | Completed | Heidelberg University | 42 | 2004-03-01 | 2012-06-29 |
| The Effect of CoQ10 Administration on Hemodialysis Patients Coenzyme Q10 (drug) - Chronic Renal Failure, Hemodialysis | Phase 4 | Completed | University of Shizuoka | 40 | 2004-03-01 | 2006-03-28 |
| Uremic Hyperhomocysteinemia -A Folate Trial for Possible Prevention of Cardiovascular Events folate treatment - Uremia, Chronic Renal Failure | Phase 4 | Completed | Universidade Estadual de Londrina | 186 | 2003-04-01 | 2018-07-26 |
Showing 20 of 23. Sign in to see all of them.
Kidney Failure, Chronic (23) · Anemia (2) · Cardiovascular Diseases (2) · Kidney Diseases (2) · Renal Insufficiency, Chronic (2) · Anemia, Iron-Deficiency (1) · Calcinosis (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Dwarfism (1) · Dwarfism, Pituitary (1) · Glucose Intolerance (1) · Hepatitis C (1) · Hepatitis C, Chronic (1) · Hyperhomocysteinemia (1)
Chronic Disease (23) · Disease Attributes (23) · Female Urogenital Diseases (23) · Female Urogenital Diseases and Pregnancy Complications (23) · Male Urogenital Diseases (23) · Pathologic Processes (23) · Pathological Conditions, Signs and Symptoms (23) · Urogenital Diseases (23) · Urologic Diseases (23) · Renal Insufficiency (22) · Kidney Diseases (21) · Renal Insufficiency, Chronic (21) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Endocrine System Diseases (3)
Acetylcysteine (1) · Adrenal Cortex Hormones (1) · Angiotensin Receptor Antagonists (1) · Basiliximab (1) · Cinacalcet (1) · Control Groups (1) · Cyclosporine (1) · Darbepoetin alfa (1) · Epoetin Alfa (1) · Everolimus (1) · Human Growth Hormone (1) · Lactic Acid (1) · Linagliptin (1) · Mycophenolic Acid (1) · Pentoxifylline (1)
Amgen (2) · Daewon Pharmaceutical Co., Ltd. (2) · AZ Sint-Jan AV (1) · Fresenius Medical Care Deutschland GmbH (1) · Heidelberg University (1) · JW Pharmaceutical (1) · Janssen Pharmaceutica N.V., Belgium (1) · Kumamoto University (1) · LG Life Sciences (1) · Ministry of Health, Malaysia (1) · National Taiwan University Hospital (1) · Novartis Pharmaceuticals (1) · Osaka General Medical Center (1) · Seoul National University Hospital (1) · Tehran University of Medical Sciences (1)
South Korea (6) · Italy (2) · Japan (2) · Austria (1) · Belgium (1) · Brazil (1) · China (1) · Finland (1) · France (1) · Germany (1) · Iran (1) · Israel (1) · Malaysia (1) · Norway (1) · Poland (1)
Altair J Mocelin, MD PHD (1) · An S De Vriese, MD, PhD (1) · Angelo Avogaro, M.D. Ph.D. (1) · Bumseok Kim, Professor (1) · Claus P Schmitt, M.D. (1) · Dong Sun, MD (1) · Gian Paolo Fadini, M.D. (1) · Hiromichi Kumagai, MD (1) · Hyeong-Cheon Park, Professor (1) · Kenichiro Kitamura, M.D., Ph.D. (1) · Kyuseok Kim, MD (1) · Mariano Feriani, MD (1)
PMID 23124784, PMID 26695864, PMID 28183314, PMID 31908426, PMID 31994788, PMID 33381933, PMID 36791280